These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32040515)

  • 1. A mathematical model for dynamics of soluble form of DNAM-1 as a biomarker for graft-versus-host disease.
    Goshima Y; Nakaoka S; Ohashi K; Sakamaki H; Shibuya K; Shibuya A
    PLoS One; 2020; 15(2):e0228508. PubMed ID: 32040515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble DNAM-1, as a Predictive Biomarker for Acute Graft-Versus-Host Disease.
    Kanaya M; Shibuya K; Hirochika R; Kanemoto M; Ohashi K; Okada M; Wagatsuma Y; Cho Y; Kojima H; Teshima T; Imamura M; Sakamaki H; Shibuya A
    PLoS One; 2016; 11(6):e0154173. PubMed ID: 27257974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxicity of Donor Natural Killer Cells to Allo-Reactive T Cells Are Related With Acute Graft-vs.-Host-Disease Following Allogeneic Stem Cell Transplantation.
    Sheng L; Mu Q; Wu X; Yang S; Zhu H; Wang J; Lai Y; Wu H; Sun Y; Hu Y; Fu H; Wang Y; Xu K; Sun Y; Zhang Y; Zhang P; Zhou M; Lai B; Xu Z; Gao M; Zhang Y; Ouyang G
    Front Immunol; 2020; 11():1534. PubMed ID: 32849519
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.
    Kim SY; Lee H; Han MS; Shim H; Eom HS; Park B; Kong SY
    Clin Lymphoma Myeloma Leuk; 2016 Sep; 16(9):527-535.e2. PubMed ID: 27375156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
    Zhang R; Wang X; Hong M; Luo T; Zhao M; Shen H; Fang J; Li X; Zang S; Chen P; Nie D; Zheng P; Wu Q; Xia L
    Oncotarget; 2017 Apr; 8(14):23360-23375. PubMed ID: 28423578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-dimensional structure discrepancy between HLA alleles for effective prediction of aGVHD severity and optimal selection of recipient-donor pairs: a proof-of-concept study.
    Han H; Yuan F; Sun Y; Liu J; Liu S; Luo Y; Liang F; Liu N; Long J; Zhao X; Kong F; Xi Y
    Oncotarget; 2015 Nov; 6(37):40337-59. PubMed ID: 26498683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of NK cell S1PR5 expression on graft versus host disease in allogeneic hematopoietic stem cell transplantation].
    Guan LX; Cai B; Gao L; Li XH; Li M; Wang LL; Gao CJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):412-5. PubMed ID: 22541110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceruloplasmin is a potential biomarker for aGvHD following allogeneic hematopoietic stem cell transplantation.
    Lv M; Ye HG; Zhao XS; Zhao XY; Chang YJ; Liu DH; Xu LP; Huang XJ
    PLoS One; 2013; 8(3):e58735. PubMed ID: 23505556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating miRNA panel for prediction of acute graft-versus-host disease in lymphoma patients undergoing matched unrelated hematopoietic stem cell transplantation.
    Gimondi S; Dugo M; Vendramin A; Bermema A; Biancon G; Cavané A; Corradini P; Carniti C
    Exp Hematol; 2016 Jul; 44(7):624-634.e1. PubMed ID: 27013207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A T-Cell Surface Marker Panel Predicts Murine Acute Graft-Versus-Host Disease.
    Bäuerlein CA; Qureischi M; Mokhtari Z; Tabares P; Brede C; Jordán Garrote AL; Riedel SS; Chopra M; Reu S; Mottok A; Arellano-Viera E; Graf C; Kurzwart M; Schmiedgen K; Einsele H; Wölfl M; Schlegel PG; Beilhack A
    Front Immunol; 2020; 11():593321. PubMed ID: 33584657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Level of Granzyme B-positive T-regulatory cells is a strong predictor biomarker of acute Graft-versus-host disease after day +30 after allo-HSCT.
    Drokov MY; Davydova JO; Kuzmina LA; Galtseva IV; Kapranov NM; Vasilyeva VA; Dubnyak DS; Koroleva OM; Mikhalcova ED; Popova NN; Parovichnikova EN; Savchenko VG
    Leuk Res; 2017 Mar; 54():25-29. PubMed ID: 28095351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles Released from Human Umbilical Cord-Derived Mesenchymal Stromal Cells Prevent Life-Threatening Acute Graft-Versus-Host Disease in a Mouse Model of Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang L; Gu Z; Zhao X; Yang N; Wang F; Deng A; Zhao S; Luo L; Wei H; Guan L; Gao Z; Li Y; Wang L; Liu D; Gao C
    Stem Cells Dev; 2016 Dec; 25(24):1874-1883. PubMed ID: 27649744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-
    Heidrich V; Bruno JS; Knebel FH; de Molla VC; Miranda-Silva W; Asprino PF; Tucunduva L; Rocha V; Novis Y; Arrais-Rodrigues C; Fregnani ER; Camargo AA
    Front Immunol; 2021; 12():692225. PubMed ID: 34220852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relationship between the IFN-gamma producing cells specific for recipient and acute graft versus host disease].
    Meng XJ; Lin MF; Cai Z
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):95-8. PubMed ID: 16732961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of the level of Reg3α protein in plasma with gastrointestinal acute graft-versus-host disease].
    Cai CS; Chen GH; Sun AN; Qiao M; Liu HW; Chen F; Wang Y; Qiu HY; Han Y; Ma X; Tang XW; Jin ZM; Fu CC; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):785-90. PubMed ID: 24989295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Composite biomarker panel for prediction of severity and diagnosis of acute GVHD with T-cell-depleted allogeneic stem cell transplants-single centre pilot study.
    Min SS; Mehra V; Clay J; Cross GF; Douiri A; Dew T; Basu TN; Potter V; Ceesay MM; Pagliuca A; Sherwood RA; Vincent RP
    J Clin Pathol; 2017 Oct; 70(10):886-890. PubMed ID: 28450387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of risk factors for the development of acute graft-versus-host disease in 151 cases of allo-hematopoietic stem cell transplantation].
    Chen Y; Lu DP; Liu KY; Dong LJ; Ren HY; Huang XJ; Chen H; Liu DH; Jiang Q; Chen YH; Xu LP; Zhang YC; Lu J; Gao ZY
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):74-7. PubMed ID: 15921621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage migratory inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hemopoietic stem cell transplant recipients.
    Lo JW; Leung AY; Huang XR; Lie AK; Metz C; Bucala R; Liang R; Lan HY
    Bone Marrow Transplant; 2002 Sep; 30(6):375-80. PubMed ID: 12235522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality, length of stay and costs associated with acute graft-versus-host disease during hospitalization for allogeneic hematopoietic stem cell transplantation.
    Yu J; Parasuraman S; Shah A; Weisdorf D
    Curr Med Res Opin; 2019 Jun; 35(6):983-988. PubMed ID: 30461314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison of clinical characteristics and prognosis of adult acute graft-versus-host disease between human leukocyte antigen- identical and -mismatched allogeneic hematopoietic stem cell transplantation].
    Zhao X; Xu L; Liu D; Han T; Wang Y; Zhang X; Yan C; Chen H; Han W; Wang J; Zhao T; Li Y; Zhang B; Zhao X; Liu K; Huang X
    Zhonghua Nei Ke Za Zhi; 2014 Jan; 53(1):35-9. PubMed ID: 24674726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.